Free Trial

Jasper Therapeutics (JSPR) Institutional Ownership

Jasper Therapeutics logo
$0.57 +0.01 (+1.71%)
Closing price 10/7/2026 04:00 PM Eastern
Extended Trading
$0.58 +0.01 (+1.11%)
As of 10/7/2026 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)

Current
Institutional Ownership
Percentage
79.85%
Number of
Institutional Buyers
(last 12 months)
24
Total
Institutional Inflows
(last 12 months)
$24.77M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$1.71M
Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

JSPR Institutional Buying and Selling by Quarter

Jasper Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Renaissance Technologies LLC177,500$156K0.0%-21.9%0.634%
5/14/2026Knott David M Jr160,789$141K0.1%-11.4%0.574%
2/19/2026T. Rowe Price Investment Management Inc.964,754$1.77M0.0%-6.2%3.448%
2/18/2026Sphera Funds Management LTD.485,401$888K0.2%-22.9%1.735%
2/18/2026Quadrature Capital Ltd67,267$123K0.0%N/A0.240%
2/18/2026Millennium Management LLC1,073,783$1.97M0.0%+194.2%3.838%
2/18/2026Engineers Gate Manager LP14,257$26K0.0%N/A0.051%
2/18/2026Boothbay Fund Management LLC793,954$1.45M0.0%+79.4%2.838%
2/17/2026ADAR1 Capital Management LLC140,000$256K0.0%N/A0.500%
2/17/2026Jain Global LLC43,301$79K0.0%N/A0.155%
2/17/2026T. Rowe Price Investment Management Inc.385,522$706K0.0%-62.5%1.378%
2/16/2026Squarepoint Ops LLC281,926$516K0.0%+1,919.5%1.008%
2/16/2026Panagora Asset Management Inc.19,362$35K0.0%N/A0.069%
2/13/2026Quarry LP99,529$182K0.0%N/A0.356%
2/12/2026Renaissance Technologies LLC227,183$416K0.0%+9.0%0.812%
2/12/2026Dimensional Fund Advisors LP18,664$34K0.0%-52.1%0.067%
2/12/2026Knott David M Jr181,389$332K0.2%+5.8%0.648%
2/10/2026Goldman Sachs Group Inc.1,746,492$3.20M0.0%+6,394.9%6.241%
2/9/2026Geode Capital Management LLC211,857$388K0.0%+61.9%0.757%
11/17/2025Armistice Capital LLC348,000$828K0.0%N/A2.141%
11/17/2025Acorn Capital Advisors LLC1,382,640$3.29M1.7%N/A8.507%
11/17/2025Woodline Partners LP1,039,751$2.48M0.0%N/A6.397%
11/17/2025Voleon Capital Management LP20,950$50K0.0%N/A0.129%
11/17/2025Velan Capital Investment Management LP2,668,395$6.21M5.8%+86.1%16.418%
11/17/2025Millennium Management LLC364,939$869K0.0%+151.3%2.245%
11/17/2025Kingdon Capital Management L.L.C.1,324,845$3.15M0.4%+93.5%8.151%
11/17/2025Boothbay Fund Management LLC442,642$1.05M0.0%N/A2.723%
11/14/2025Two Sigma Investments LP40,427$96K0.0%N/A0.249%
11/14/2025Squarepoint Ops LLC13,960$33K0.0%-45.0%0.086%
11/13/2025Knott David M Jr171,389$408K0.2%N/A1.055%
11/12/2025Propel Bio Management LLC1,028,806$2.45M2.5%N/A6.331%
11/12/2025Dimensional Fund Advisors LP38,963$93K0.0%-12.8%0.240%
11/7/2025Readystate Asset Management LP98,439$234K0.0%N/A0.606%
11/7/2025Vanguard Group Inc.1,032,842$2.46M0.0%+65.4%6.356%
10/20/2025Simplify Asset Management Inc.609,053$1.45M0.0%N/A3.748%
10/17/2025Sowell Financial Services LLC10,400$25K0.0%-39.9%0.064%
8/19/2025Marex Group plc13,300$74K0.0%N/A0.089%
8/15/2025Engineers Gate Manager LP13,972$78K0.0%N/A0.093%
8/15/2025Bank of America Corp DE293,460$1.63M0.0%-18.6%1.954%
8/14/2025Jane Street Group LLC132,905$738K0.0%N/A0.885%
A dividend every week of the year (Ad)

Most dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering real expenses, that rhythm rarely lines up with the bills. Nathan Slaughter, Chief Investment Strategist at High-Yield Investing, built a full 52-week calendar by sequencing quality dividend payers so every week is covered, including bonus dividends that cluster from December through February.tc pixel

Get instant access to the full dividend calendar now
8/13/2025Marshall Wace LLP50,686$281K0.0%N/A0.337%
8/12/2025XTX Topco Ltd27,348$152K0.0%N/A0.182%
8/12/2025JPMorgan Chase & Co.65,088$361K0.0%+1,074.7%0.433%
8/8/2025Geode Capital Management LLC131,130$728K0.0%-50.3%0.873%
8/5/2025Corton Capital Inc.10,004$56K0.1%-62.1%0.067%
8/5/2025Bank of Montreal Can158,133$878K0.0%+120.4%1.053%
7/14/2025Sowell Financial Services LLC17,303$96K0.0%-16.9%0.115%
6/27/2025Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556%
5/21/2025Acadian Asset Management LLC10,708$46K0.0%N/A0.071%
5/16/2025Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556%
5/15/2025Kingdon Capital Management L.L.C.490,000$2.11M0.2%+9.6%3.262%
5/14/2025T. Rowe Price Investment Management Inc.702,757$3.02M0.0%+755.3%4.678%
5/12/2025Nuveen LLC102,268$440K0.0%N/A0.681%
5/9/2025Charles Schwab Investment Management Inc.26,648$115K0.0%-17.6%0.177%
5/7/2025Corton Capital Inc.26,382$113K0.4%N/A0.176%
4/17/2025Sowell Financial Services LLC20,825$90K0.0%-25.7%0.139%
3/24/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/27/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Woodline Partners LP245,676$5.25M0.0%-50.4%1.638%
2/17/2025Soleus Capital Management L.P.1,494,420$31.95M2.0%+11.2%9.962%
2/17/2025Tema Etfs LLC12,435$266K0.1%N/A0.083%
2/17/2025Stempoint Capital LP135,244$2.89M0.7%N/A0.902%
2/17/2025Integral Health Asset Management LLC650,000$13.90M1.2%+85.7%4.333%
2/17/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Deutsche Bank AG170,695$3.65M0.0%+30.0%1.138%
2/17/2025Braidwell LP714,658$15.28M0.5%+47.9%4.764%
2/17/2025Bank of America Corp DE287,204$6.14M0.0%-11.9%1.915%
2/17/2025Allostery Investments LP22,000$470K0.5%N/A0.147%
2/17/2025Ally Bridge Group NY LLC122,424$2.62M2.2%-69.4%0.816%
2/14/2025Boxer Capital Management LLC350,000$7.48M0.6%N/A2.333%
2/14/2025Jane Street Group LLC10,852$232K0.0%-18.7%0.072%
2/14/2025Northern Trust Corp104,367$2.23M0.0%-2.4%0.696%
2/14/2025Propel Bio Management LLC20,000$428K0.4%N/A0.133%
2/14/2025T. Rowe Price Investment Management Inc.82,165$1.76M0.0%N/A0.548%
2/14/2025Rock Springs Capital Management LP463,088$9.90M0.4%+0.9%3.087%
2/13/2025Marshall Wace LLP77,722$1.66M0.0%+17.2%0.518%
2/13/2025Mariner LLC36,794$787K0.0%-12.8%0.245%
2/13/2025Barclays PLC18,334$392K0.0%+13.6%0.122%
2/13/2025Russell Investments Group Ltd.247,272$5.29M0.0%+16.9%1.648%
2/13/2025Wells Fargo & Company MN7,415$159K0.0%+106.7%0.049%
2/12/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/12/2025Schroder Investment Management Group59,034$1.24M0.0%N/A0.394%
2/12/2025JPMorgan Chase & Co.5,165$110K0.0%-68.5%0.034%
2/11/2025EntryPoint Capital LLC10,431$223K0.1%N/A0.070%
2/11/2025Simplify Asset Management Inc.20,000$428K0.0%N/A0.133%
1/30/2025Rhumbline Advisers14,761$316K0.0%+12.6%0.098%
12/26/2024JPMorgan Chase & Co.16,391$308K0.0%+239.8%0.109%
11/27/2024Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864%
11/19/2024Barclays PLC16,146$304K0.0%+320.7%0.108%
11/16/2024Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704%
“Whoever wins AI, wins” (Ad)

Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent.tc pixel

See the light-speed AI technology and get Jason's number one pick free
11/15/2024Barclays PLC16,146$304K0.0%+320.7%0.107%
11/15/2024Jane Street Group LLC13,354$251K0.0%N/A0.088%
11/15/2024Wellington Management Group LLP23,759$447K0.0%N/A0.157%
11/15/2024State Street Corp214,883$4.04M0.0%+12.3%1.423%
11/15/2024Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872%
11/15/2024Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365%
11/14/2024Braidwell LP483,300$9.09M0.3%N/A3.201%
11/14/2024Verition Fund Management LLC25,353$477K0.0%N/A0.168%
11/14/2024Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645%
11/14/2024MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046%


JSPR Institutional Ownership - Frequently Asked Questions

During the previous two years, 71 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($31.95M), Braidwell LP ($15.28M), Integral Health Asset Management LLC ($13.90M), Samsara BioCapital LLC ($11.00M), Franklin Resources Inc. ($10.90M), Rock Springs Capital Management LP ($9.90M), and Boxer Capital Management LLC ($7.48M).Learn more on Jasper Therapeutics' institutional investors.

79.85% of Jasper Therapeutics' stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings.

Of the 61 institutional investors that purchased Jasper Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Goldman Sachs Group Inc. ($1.77M), Acorn Capital Advisors LLC ($1.38M), Velan Capital Investment Management LP ($1.23M), Propel Bio Management LLC ($1.05M), Woodline Partners LP ($1.04M), Millennium Management LLC ($928.56K), and Boothbay Fund Management LLC ($793.95K).

Institutional investors have bought a total of 11,225,892 shares in the last 24 months. This purchase volume represents approximately $24.77M in transactions.

The following institutional investors have sold Jasper Therapeutics stock in the last 24 months: T. Rowe Price Investment Management Inc. ($707.34K), Sphera Funds Management LTD. ($144.07K), Renaissance Technologies LLC ($49.68K), Dimensional Fund Advisors LP ($26.00K), Knott David M Jr ($20.60K), Squarepoint Ops LLC ($11.42K), and Sowell Financial Services LLC ($6.90K).

Institutional investors have sold a total of 966,007 shares in the last 24 months. This volume of shares sold represents approximately $1.71M in transactions.



Institutional ownership data for NASDAQ:JSPR is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 5/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners